...
首页> 外文期刊>The biochemical journal >The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system
【24h】

The presence of atrial-natriuretic-factor receptors of ANF-R2 subtype in rat platelets. Coupling to adenylate cyclase/cyclic AMP signal-transduction system

机译:大鼠血小板中ANF-R2亚型的心钠素受体受体的存在。偶联腺苷酸环化酶/环AMP信号转导系统

获取原文
   

获取外文期刊封面封底 >>

       

摘要

pThe effect of atrial natriuretic factor (ANF) on adenylate cyclase activity was studied in rat platelet membranes. ANF-(99-126)-, -(101-126)-, -(103-126)- and -(103-123)-peptide inhibited adenylate cyclase activity in a concentration-dependent manner with an order of potency of ANF-(103-123)-peptide greater than ANF-(99-126)-peptide greater than ANF-(101-126)-peptide greater than ANF-(103-126)-peptide. ANF-(103-123)-peptide and ANF-(99-126)-peptide inhibited the enzyme activity by about 50-55%, with an apparent Ki between 0.1 and 0.5 nM, and ANF-(101-126)-peptide inhibited the enzyme activity by about 35%, with an apparent Ki between 1 and 3 nM. On the other hand, ANF-(103-126)-peptide was the least potent and inhibited the adenylate cyclase activity by about 30% (Ki approximately 10 nM). The inhibitory effect of ANF on adenylate cyclase was also dependent on the presence of guanine nucleotides and was attenuated by amiloride and pertussis toxin. The stimulatory effects of various agonists such as N-ethylcarboxamideadenosine, prostaglandin E1, isoprenaline and forskolin on adenylate cyclase were also inhibited by ANF to various extents; however, the stimulations were not completely abolished. In addition, 125I-labelled ANF-(99-126)-peptide bound specifically to rat platelet membranes. The binding of 125I-ANF was competitively inhibited in a concentration-dependent manner by the unlabelled peptides which were used for adenylate cyclase inhibition. ANF-(103-123)-peptide, ANF-(99-126)-peptide and ANF-(101-126)-peptide were almost equipotent [IC50 (median inhibitory concentration) = 0.1-1 nM], and ANF-(103-126)-peptide was the least potent (IC50 approximately 10 nM). Scatchard analysis of the data revealed the presence of a single class of binding sites of high affinity (Kd approximately 120 pM). Affinity cross-linking of 125I-ANF-(99-126)-peptide to its binding sites in rat platelet membranes and analysis by SDS/PAGE followed by autoradiography showed a predominant labelling of a protein band with an apparent Mr of 66,000. These data indicate the presence of only ANF-R2 (low-Mr) receptors in platelets and suggest that these receptors may be coupled to the adenylate cyclase system./p
机译:>在大鼠血小板膜中研究了心钠素对腺苷酸环化酶活性的影响。 ANF-(99-126)-,-(101-126)-,-(103-126)-和-(103-123)-肽以浓度依赖性的方式抑制腺苷酸环化酶活性,其效价顺序为ANF -(103-123)-肽大于ANF-(99-126)-肽大于ANF-(101-126)-肽大于ANF-(103-126)-肽。 ANF-(103-123)-肽和ANF-(99-126)-肽抑制酶活性约50-55%,表观Ki在0.1-0.5 nM之间,而ANF-(101-126)-肽抑制酶活性约35%,表观Ki在1-3 nM之间。另一方面,ANF-(103-126)-肽的效力最弱,并且抑制腺苷酸环化酶活性约30%(Ki约10 nM)。 ANF对腺苷酸环化酶的抑制作用还取决于鸟嘌呤核苷酸的存在,并被阿米洛利和百日咳毒素减弱。 ANF也对N-乙基羧酰胺腺苷,前列腺素E1,异丙肾上腺素和毛喉素等多种激动剂对腺苷酸环化酶的刺激作用产生了不同程度的抑制作用。但是,刺激并未完全消除。另外,125 I标记的ANF-(99-126)-肽特异性结合至大鼠血小板膜。 125 I-ANF的结合以浓度依赖性方式被未标记的肽竞争性抑制,该肽用于抑制腺苷酸环化酶。 ANF-(103-123)-肽,ANF-(99-126)-肽和ANF-(101-126)-肽几乎相等[IC50(中值抑制浓度)= 0.1-1 nM],ANF-( 103-126)-肽的效力最低(IC50约为10 nM)。数据的Scatchard分析揭示了高亲和力(Kd约120pM)的单类结合位点的存在。 125I-ANF-(99-126)-肽与其在大鼠血小板膜上的结合位点的亲和力交联,并通过SDS / PAGE和放射自显影进行分析,显示主要标记蛋白带,表观Mr值为66,000。这些数据表明血小板中仅存在ANF-R2(低Mr)受体,并暗示这些受体可能与腺苷酸环化酶系统偶联。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号